Safeguard Scientifics(SFES)
$0.59-0.01 (-1.67%)
SFES
Safeguard Scientifics financials statements
$0.59
At close:-0.01 (-1.67%)
Want to see SFES full AI Analyst Report?
Safeguard Scientifics (SFES) Ratios
64 Followers
Safeguard Scientifics Ratios
SFES's free cash flow for Q4 2024 was $-302.00K. For the 2024 fiscal year, SFES's free cash flow was increased by $0.00 and operating cash flow was $-302.00K. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.83 | 4.84 | 11.79 | 17.46 | 4.63 |
| Quick Ratio | 5.83 | 4.84 | 11.79 | 17.46 | 4.63 |
| Cash Ratio | 5.56 | 4.64 | 7.34 | 14.27 | 4.50 |
| Solvency Ratio | -6.78 | -3.33 | -4.49 | 7.87 | -6.06 |
| Operating Cash Flow Ratio | -2.43 | -1.62 | -1.79 | -4.70 | -2.35 |
| Short-Term Operating Cash Flow Coverage | -5.34 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 5.67M | $ 7.05M | $ 18.31M | $ 26.82M | $ 9.90M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.05 | 0.04 | 0.04 | 0.03 |
| Debt-to-Equity Ratio | 0.08 | 0.06 | 0.05 | 0.04 | 0.04 |
| Debt-to-Capital Ratio | 0.07 | 0.06 | 0.05 | 0.04 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.15 | 1.14 | 1.09 | 1.07 | 1.10 |
| Debt Service Coverage Ratio | -17.94 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.05 | 0.08 | 0.10 | 0.10 | 0.11 |
| Net Debt to EBITDA | 0.60 | 0.87 | 0.83 | -0.83 | 0.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 395.32% | 172.94% | 298.70% | -377.52% | 397.37% |
| Return on Assets (ROA) | -91.87% | -43.04% | -37.84% | 49.98% | -54.49% |
| Return on Equity (ROE) | -105.68% | -49.19% | -41.25% | 53.40% | -59.83% |
| Return on Capital Employed (ROCE) | -26.06% | -27.34% | -13.31% | -13.68% | -14.44% |
| Return on Invested Capital (ROIC) | -24.70% | -26.71% | -13.15% | -13.58% | -14.37% |
| Return on Tangible Assets | -91.87% | -43.04% | -37.84% | 49.98% | -54.49% |
| Earnings Yield | -72.46% | -77.68% | -28.16% | 18.53% | -28.41% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 2.98 | 16.94 | 5.59 | 5.55 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -122.43 | -21.55 | -65.35 | -65.72 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 122.43 | 21.55 | 65.35 | 65.72 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.18 | -0.20 | -0.20 | -0.41 | -0.39 |
| Free Cash Flow Per Share | -0.18 | -0.20 | -0.20 | -0.41 | -0.39 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -0.57 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -3.92 | -2.65 | -1.94 | -3.97 | -3.42 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -20.77% | -26.15% | -6.43% | -5.59% | -6.15% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.39 | -1.29 | -3.55 | 5.40 | -3.52 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.46 | 0.63 | 1.46 | 2.88 | 2.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.81 | -3.82 | -15.54 | -17.88 | -16.26 |
| Price-to-Operating Cash Flow Ratio | -4.81 | -3.82 | -15.54 | -17.88 | -16.26 |
| Price-to-Earnings Growth (PEG) Ratio | -0.85 | 0.04 | 0.02 | -0.03 | 0.02 |
| Enterprise Value Multiple | -0.83 | -0.46 | -2.79 | 4.52 | -3.19 |
| Enterprise Value | 8.28M | 4.40M | 38.99M | 123.04M | 119.17M |
| EV to EBITDA | -0.83 | -0.46 | -2.79 | 4.52 | -3.19 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -2.78 | -1.33 | -11.97 | -15.09 | -14.63 |
| EV to Operating Cash Flow | -2.78 | -1.33 | -11.97 | -15.09 | -14.63 |
| Tangible Book Value Per Share | 0.59 | 1.23 | 2.12 | 2.55 | 3.03 |
| Shareholders’ Equity Per Share | 0.59 | 1.23 | 2.12 | 2.55 | 3.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.62 | -0.61 | -0.87 | 1.36 | -1.81 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.29 | 0.34 | 0.23 | -0.30 | 0.22 |
Currency in USD

